STAT+: Drugmakers rely on ‘use codes’ to vastly expand the nature of their patent claims, STAT analysis shows
Amid debate over potential abuse of the U.S. patent system by the pharmaceutical industry, moves…
Category: patents
Morning Rounds: Apple Watch takes on sleep apnea and tonight’s presidential debate
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions…
STAT+: Biden administration appeals jury finding in battle over patents for HIV prevention pills
The Biden administration has appealed a decision in which a federal court jury last year…
Opinion: Senate, FTC cracking down on pharma patent shenanigans
Why do Americans pay so much more for common medications than people in other countries?…
STAT+: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?
In a bid to prevent the patent system from being abused, the U.S. Patent and…
Opinion: Cutting-edge insulin is good. But it’s the ‘trailing edge’ of older versions that can keep it affordable
Physicians Frederick Banting and John MacLeod declined to be listed on the patent for insulin…
STAT+: FDA is criticized for taking a ‘ministerial’ role in sorting out some pharma patents
When it comes to a crucial controversy over pharmaceutical patents, the FDA has been MIA….
STAT+: Gilead gets a boost from California court in a case over slow-walking an HIV drug
In a boost for Gilead Sciences, the California Supreme Court agreed to review a contentious…
STAT+: FTC issues more warnings to drug companies for ‘junk’ patent listings
The U.S. Federal Trade Commission expanded its campaign against pharmaceutical companies for filing what it…
Opinion: Déjà WTO: The WHO’s pandemic agreement shouldn’t water down intellectual property obligations
As countries resume final negotiations on Monday for a landmark pandemic agreement intended to help…
STAT+: Biden administration urged to license prostate cancer drug patents in a bid to lower its cost
In the latest gambit to lower the cost of a pricey medicine, three advocacy groups…
STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the…
STAT+: WTO proposal for Covid diagnostics and therapeutics waiver is abandoned
After 18 months of debate, the World Trade Organization failed to adopt a controversial proposal…
STAT+: AbbVie CEO Gonzalez to step down after a decade fiercely defending its top seller, Humira
AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it…
STAT+: Leaked version of EFTA-India free trade deal sparks alarm over access to medicines
A leaked version of a proposed agreement between India and the European Free Trade Association…
STAT+: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV
The Colombian government has taken a significant step toward issuing a compulsory license for a…
CDC and social media: The new misinformation war
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Diabetes treatments have improperly listed patents that should be removed, analysis finds
More than half of the injector-pen patents for several widely used diabetes treatments — including…
STAT+: WTO appears close to rejecting a proposed waiver on patents for Covid diagnostics and therapies
After more than a year of deliberation, the World Trade Organization appears close to rejecting…
Opinion: The Biden administration should not support a WTO petition to strip IP protections from Covid-19 treatments
The Biden administration may soon double down on one of its gravest mistakes. In 2022,…
STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’
Over the past two years, the U.S. Federal Trade Commission has attempted to crack down…
STAT+: In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property
In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer…
STAT+: Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate
Amid a push to crack down on patent abuse by the pharmaceutical industry, a key…
STAT+: Apple removes pulse oximeter feature in Watches to comply with ban
Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced…
STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision
WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally…
STAT+: New congressional bill would thwart patent thickets in order to speed generic drugs to market
In the latest bid to lower the cost of medicines, a new bill was introduced…
STAT+: Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace
To ring the register, a pharmaceutical company may create a patent thicket, which involves filing…
STAT+: Biden proposal targeting pharma patents spurs industry fears and consumer doubts
Will this be a half a loaf? After months of deliberation, the Biden administration on…
STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer…
STAT+: To lower drug prices, White House takes new aim at pharma patents
WASHINGTON — The White House is throwing its support behind a controversial authority that allows…
STAT+: Vertex pushes a donation program to widen access to cystic fibrosis treatments, but advocates say it’s not enough
Vertex Pharmaceuticals is being accused by a group of advocates and physicians of refusing to…
STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds
The patents on medicines and devices approved by the U.S. Food and Drug Administration were…
Opinion: Patent buyouts could spur vital innovation in antibiotics, vaccines, and other medical fields
The announcement by the Center for Medicare and Medicaid Services that ten drugs will be…
STAT+: FTC challenges several big drugmakers over inaccurate or improper patent listings
Making good on a recent threat, the U.S. Federal Trade Commission is challenging more than…
STAT+: ITC recommends partial import ban of Apple watches in Masimo patent case
The United States International Trade Commission issued a partial import ban of Apple watches on…
STAT+: Lilly complains to the U.S. International Trade Commission about unapproved versions of Mounjaro
As demand for weight-loss treatments intensifies, Eli Lilly has filed a complaint with the U.S….
STAT+: Biotech investors push to extend time before pills are subject to price negotiations
The fight over drug prices is far from over. Investors in biopharma companies, who lobbied…
STAT+: Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV
In the latest battle over access to medicines, Colombian authorities have decided to issue a…
STAT+: How a cash-prize system that phases out patents may lower drug prices
Two months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he…
STAT+: FTC warns drugmakers they can face legal action over improper patent filings
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly…
STAT+: Lawmakers introduce bill to require drugmakers to provide key info to both FDA and U.S. Patent Office
Amid concerns over monopolies held by drugmakers, a bipartisan group of lawmakers introduced a bill…
Is there a path forward for PEPFAR?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
Opinion: STAT+: What Mark Cuban gets wrong about prescription drugs
Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently…
STAT+: Bernie Sanders wants to replace drug patents with prizes for breakthrough medicines
WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to…
Biden’s NIH nominee is languishing in Congress — alarming public health advocates
WASHINGTON — Sen. Bernie Sanders’ rare move to delay President Biden’s health care nominees has…
STAT+: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
In a setback to AIDS activists, a federal court jury on Friday cleared Gilead Sciences…
STAT+: If AI invents a new medicine, who gets the patent?
Pharmaceutical and biotech companies are increasingly using artificial intelligence to discover and make drugs and…
STAT+: What the Covid-19 pandemic can teach us about drug patents
Inventing treatments and vaccines is only part of the battle in an epidemic and pandemic,…
Opinion: STAT+: 3 keys to successful biopharma-academia drug development collaborations
Academia can be an excellent source of novel drug targets and new technologies that can…